UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT

Blood, 2017-10, Vol.130 (17), p.1946-1948

2017

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now

Blood, 2011-08, Vol.118 (5), p.1197-1207

2011

Volltextzugriff (PDF)

Co-expression of Foxp3 and Helios facilitates the identification of human T regulatory cells in health and disease

Frontiers in immunology, 2023-06, Vol.14, p.1114780-1114780

2023

Volltextzugriff (PDF)

Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia

PloS one, 2015-11, Vol.10 (11), p.e0141706

2015

Volltextzugriff (PDF)

Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease

Hematology, 2022-12, Vol.2022 (1), p.266-271

Fitzhugh, Courtney D

2022

Volltextzugriff (PDF)

Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT

Blood advances, 2017-04, Vol.1 (11), p.652-661

2017

Volltextzugriff (PDF)

Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease

Frontiers in immunology, 2021-11, Vol.12, p.757279-757279

2021

Volltextzugriff (PDF)

Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease

Journal of clinical medicine, 2022-06, Vol.11 (11), p.3160

2022

Volltextzugriff (PDF)

The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia

Blood advances, 2017-12, Vol.1 (26), p.2563-2567

2017

Volltextzugriff (PDF)

Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation

Blood, 2020-04, Vol.135 (14), p.1185-1188

2020

Volltextzugriff (PDF)

Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies

Journal of clinical medicine, 2022-05, Vol.11 (11), p.3118

2022

Volltextzugriff (PDF)

Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype

JAMA : the journal of the American Medical Association, 2014-07, Vol.312 (1), p.48

2014

Volltextzugriff (PDF)

TP53 mutation screening for patients at risk of myeloid malignancy

Leukemia, 2024-07, Vol.38 (7), p.1604-1608

2024

Volltextzugriff (PDF)

Riociguat shows remarkable safety but underwhelming activity in patients with sickle cell disease

The Lancet. Haematology, 2024-05, Vol.11 (5), p.e313-e314

2024

Volltextzugriff (PDF)

Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease

The New England journal of medicine, 2009-12, Vol.361 (24), p.2309-2317

2009

Volltextzugriff (PDF)

Pain and opioid use after reversal of sickle cell disease following HLA‐matched sibling haematopoietic stem cell transplant

British journal of haematology, 2019-02, Vol.184 (4), p.690-693

2019

Volltextzugriff (PDF)

Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study

The Lancet. Haematology, 2019-11, Vol.6 (11), p.e585-e596

2019

Volltextzugriff (PDF)

Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure

Hematology/oncology clinics of North America, 2022-12, Vol.36 (6), p.1313-1335

2022

Volltextzugriff (PDF)

Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease

Journal of clinical oncology, 2023-04, Vol.41 (12), p.2227-2237

2023

Volltextzugriff (PDF)

When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease

Seminars in hematology, 2018-04, Vol.55 (2), p.94-101

2018

Volltextzugriff (PDF)

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease

Blood, 2020-07, Vol.136 (5), p.623-626

2020

Volltextzugriff (PDF)

Cardiac effects 2 years after successful non‐myeloablative human leukocyte antigen‐matched related donor hematopoietic cell transplants in sickle cell disease

American journal of hematology, 2023-08, Vol.98 (8), p.E219-E221

2023

Volltextzugriff (PDF)

The challenge of eliciting opinions of gene therapy for SCD

Blood advances, 2023-12, Vol.7 (23), p.7369-7370

2023

Volltextzugriff (PDF)

Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies

Blood cells, molecules, & diseases, 2017-09, Vol.67, p.155-168

2017

Volltextzugriff (PDF)

Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model

Bone marrow transplantation (Basingstoke), 2024-05, Vol.59 (5), p.615-624

2024

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(97)
Buchkapitel
(1)

Sprache

Englisch
(98)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(50)
Humans
(42)
Hematology
(41)
Sickle Cell Disease
(23)
Anemia, Sickle Cell - Therapy
(21)
Adult
(20)
Female
(17)
Male
(16)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(13)
Immunology
(11)
Middle Aged
(11)
Transplantation
(11)
Adolescent
(10)
Anemia, Sickle Cell - Complications
(10)
Hematopoietic Stem Cell Transplantation - Methods
(10)
Oncology
(8)
Retrospective Studies
(8)
Sickle Cell Anemia
(8)
Transplantation, Homologous
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now

Co-expression of Foxp3 and Helios facilitates the identification of human T regulatory cells in health and disease

Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia

Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease

Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT

Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease

Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease

The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia

Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation

Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies

Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype

TP53 mutation screening for patients at risk of myeloid malignancy

Riociguat shows remarkable safety but underwhelming activity in patients with sickle cell disease

Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease

Pain and opioid use after reversal of sickle cell disease following HLA‐matched sibling haematopoietic stem cell transplant

Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study

Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure

Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease

When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease

Cardiac effects 2 years after successful non‐myeloablative human leukocyte antigen‐matched related donor hematopoietic cell transplants in sickle cell disease

The challenge of eliciting opinions of gene therapy for SCD

Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies

Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model

Suchergebnisse filtern